Phase I study of the combination of anti-GD2 antibody 3F8 and barley-derived (1→3,1→4)-ß-D-glucan for patients with resistant neuroblastoma Meeting Abstract
| Authors: | Modak, S.; Kushner, B. H.; Kramer, K.; Vickers, A.; Cheung, N. |
| Abstract Title: | Phase I study of the combination of anti-GD2 antibody 3F8 and barley-derived (1→3,1→4)-ß-D-glucan for patients with resistant neuroblastoma |
| Meeting Title: | 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 25 |
| Issue: | 18 Suppl. |
| Meeting Dates: | 2007 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2007-06-20 |
| Start Page: | 542s |
| Language: | English |
| ACCESSION: | WOS:000455043702523 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2007.25.18_suppl.9566 |
| Notes: | Meeting Abstract: 9566 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work